SupremacieNX Jour (Ventura Corporation, LTDA)


Welcome to the PulseAid listing for the Supremacie drug offered from Ventura Corporation, LTDA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Ventura Corporation, LTDA
NON-PROPRIETARY NAME: Ensulizole, Homosalate, Octinoxate, and Oxybenzone
SUBSTANCE NAME: ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2010-02-19
END MARKETING DATE: 0000-00-00


Supremacie NX Jour HUMAN OTC DRUG Details:

Item DescriptionSupremacie NX Jour from Ventura Corporation, LTDA
LABELER NAME: Ventura Corporation, LTDA
DEA SCHEDULE:
ACTIVE STRENGTH: .001; .001; .00375; .002(g/5g; g/5g; g/5g; g/5g)
START MARKETING DATE: 2010-02-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 13537-261_c5dc0cbd-4b27-43dd-ab25-896c012a439a
PRODUCT NDC: 13537-261
APPLICATION NUMBER: part352

Other ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ventura Corporation, LTDLBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin
Ventura Corporation, LTDASupremacie
Ventura International, LTDLBEL SUPREMACIE NX JOUR Replenishing Treatment Daytime Face SPF 15 Normal To Dry Skin